7S3-28162-29462
3 vaccinations
2 coded responses
27 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 945 / CA
- Registered
- 2021-03-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2021-03-19
Registered in v-safe
-
2021-03-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to workAdult check-in
- 2021-03-20
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Fair · Site: Pain · HeadacheFree text: I have been sweating profusely every night since the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-04-29
Survey response — day 42, dose 2MedDRA: Anxiety — Feeling: FairFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-17
- 2021-09-16
-
2022-02-17
Dose 3 — Pfizer-BioNTech
- 2022-02-17
-
2022-02-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-02-19
-
2022-02-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body achesAdult check-in
- 2022-02-21
- 2022-02-23
- 2022-02-24
- 2022-03-03
- 2022-03-10
- 2022-03-17
- 2022-03-24
- 2022-05-19
- 2022-08-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | |
| 2 | 2021-03-18 | Pfizer-BioNTech | |
| 3 | 2022-02-17 | Pfizer-BioNTech | No |
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): I have been sweating profusely every night since the vaccine
Release 8 — day 42, dose 2
Symptoms: Anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Anxiety | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release